Scientific ReportsGeneticsPeer-reviewed journal article
Copy number variants implicate cardiac function and development pathways in earthquake-induced stress cardiomyopathy
Cameron James LaceyiD, Kit DoudneyiD, Paul Gavin BridgmaniD, Peter M. George, Roger MulderiD, Julie Zarifeh, Bridget Kimber, Murray J. CadzowiD, Michael A. BlackiD, Tony Raymond MerrimaniD, Klaus LehnertiD, Vivienne M. Bickley, John F. PearsoniD, Vicky A. CameroniD, Martin Alexander KennedyiD
Abstract
The pathophysiology of stress cardiomyopathy (SCM), also known as takotsubo syndrome, is poorly understood. SCM usually occurs sporadically, often in association with a stressful event, but clusters of cases are reported after major natural disasters. There is some evidence that this is a familial condition. We have examined three possible models for an underlying genetic predisposition to SCM. Our primary study cohort consists of 28 women who suffered SCM as a result of two devastating earthquakes that struck the city of Christchurch, New Zealand, in 2010 and 2011. To seek possible underlying genetic factors we carried out exome analysis, Cardio-MetaboChip genotyping array analysis and array comparative genomic hybridization on these subjects. The most striking finding from these analyses was the observation of a markedly elevated rate of rare, heterogeneous copy number variants (CNV) of uncertain clinical significance (in 12/28 subjects). Several of these CNVs clearly impacted on genes of cardiac relevance including RBFOX1, GPC5, KCNRG, CHODL, and GPBP1L1. There is no physical overlap between the CNVs, and the genes they impact do not fall into a clear pathophysiological pathway. However, the recognition that SCM cases display a high rate of unusual CNV, and that SCM predisposition may therefore be associated with these CNVs, offers a novel perspective and a new approach by which to understand this enigmatic condition.
- organism: human
- assay: whole-exome sequencing
- research focus: variant calling
- approach: statistical model
- Citations
- 13
- FWCI
- 1.13
- Field percentile
- top 19%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mechanisms of Pathogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant R278C+/- During Development
S. Shafaattalab, A. Y. LI, … G. F. Tibbits·bioRxiv·Jun 6, 2023
- Outcomes and phenotypic expression of rare variants in hypertrophic cardiomyopathy genes amongst UK Biobank participants
Antonio de Marvao, Kathryn A. McGurk, … Declan P. O’Regan·Journal of the American College of CardiologyPeer-reviewed·Sep 1, 2021
- A contraction stress model of hypertrophic cardiomyopathy due to thick filament sarcomere mutations
R. Cohn, K. Thakar, … J. T. Hinson·bioRxiv·Sep 4, 2018
- The genetic architecture of left ventricular non-compaction reveals both substantial overlap with other cardiomyopathies and a distinct aetiology in a subset of cases
Francesco Mazzarotto, Megan H. Hawley, … Roddy Walsh·Genetics in MedicinePeer-reviewed·Jan 26, 2021
- Spatial genomics of the cardiac sarcomere
Christian Cadisch, Victoria Nicole Parikh, … Euan Angus Ashley·bioRxiv·Oct 7, 2025
- Loss-of-Function FLNC Variants are Associated with Arrhythmogenic Cardiomyopathy Phenotypes when Identified through Exome Sequencing of a General Clinical Population
Eric D. Carruth, Maria Qureshi, … Christopher M. Haggerty·Circulation Genomic and Precision MedicinePeer-reviewed·Jun 14, 2022